Activity of vancomycin release from bioinspired coatings of hydroxyapatite or TiO2 nanotubes

Int J Pharm. 2017 Jan 30;517(1-2):296-302. doi: 10.1016/j.ijpharm.2016.11.062. Epub 2016 Nov 30.

Abstract

Herein we investigate the efficiency of various biomimetic coatings for localized drug delivery, using vancomycin as key therapeutic drug, which is a widely used antibiotic for the treatment of strong infections caused by positive Gram bacteria. We evaluate classical hydroxyapatite and biomimetic hydroxyapatite-collagen coatings obtained by electrochemical deposition as well as TiO2 nanotubes arrays obtained by electrochemical anodization. Surface morphology, compositional and structural data confirm the incorporation of vancomycin into the layers and drug release profiles for vancomycin evaluate their release ability. Namely, hydroxyapatite coatings lead to a ≈92% vancomycin release after 30h and hydroxyapatite-collagen to 85%, while the TiO2 nanotubes layers lead to 78% release. The antibacterial effect of such drug loaded coatings is evaluated against S. aureus (Gram-positive bacteria). Our study shows that the vancomycin incorporated hydroxyapatite coatings lead to a faster release, while the nanotubular coatings may lead to longer time release and additionally both types of coatings ensure a good antibacterial inhibition.

Keywords: Hydroxyapatite; Hydroxyapatite-collagen coatings; S. aureus; TiO(2) nanotubes; Vancomycin.

MeSH terms

  • Coated Materials, Biocompatible / chemistry*
  • Collagen / chemistry
  • Drug Liberation
  • Durapatite / chemistry*
  • Microbial Sensitivity Tests
  • Nanotubes / chemistry*
  • Nanotubes / ultrastructure
  • Titanium / chemistry*
  • Vancomycin / chemistry
  • Vancomycin / pharmacokinetics*
  • Vancomycin / pharmacology*

Substances

  • Coated Materials, Biocompatible
  • titanium dioxide
  • Vancomycin
  • Collagen
  • Durapatite
  • Titanium